|
Match
|
Document |
Document Title |
|
|
5985917 |
Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
This invention is directed to a pharmacologically acceptable composition for inhibiting nitric oxide synthase in a mammal, which includes a mercapto or seleno derivative and a pharmaceutically...
|
|
|
5972940 |
Arginine analogues having nitric oxide synthase inhibitor activity
A compound selected from the group consisting of a compound of the formula wherein A is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms and --NO 2 , E is --O-- or a...
|
|
|
5965529 |
Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
Preeclampsia and preterm labor in a pregnant female mammal are treated by administering thereto a combination of a progestin and a nitric oxide synthase substrate, a nitric oxide donor or both,...
|
|
|
5952385 |
Mercapto derivatives as inhibitors of nitric oxide synthase
This invention is directed to a pharmacologically acceptable composition for inhibiting nitric oxide synthase in a mammal, which includes a mercapto derivative and a pharmaceutically acceptable...
|
|
|
5945455 |
Amine and amidine containing compounds as weight reducing agents
Use of amine and amidine containing compounds of formula (I) such as galegine and related substituted amine and amidine containing compounds as agents for reducing weight in mammals, pharmaceutical...
|
|
|
5939078 |
Wrinkle-care product
A wrinkle-care product, an aging-preventive cosmetic and a skin cosmetic each comprising a guanidine derivative of formula (I) or an acid addition salt thereof: ##STR1## wherein R1 represents a...
|
|
|
5929120 |
Guainidino, formamidino, amino and related compounds for inhibiting osteoclast-mediated bone resorption
Compounds of the following general structure X--Y--Z-Aryl-A--B, ##STR1## which inhibit osteoclast mediated bone resorption.
|
|
|
5929055 |
Therapeutic method for management of diabetes mellitus
A method for treating diabetes in a mammal by moderately controlling blood glucose concentration in the mammal together with administering to the mammal an amount of a tetracycline compound...
|
|
|
5922769 |
Glibenclamide-metformin combination for the treatment of diabetes mellitus of type II
Non-insulin dependent diabetes mellitus in cases of secondary failure is treated with a combination of glibenclamide and metformin.
|
|
|
5922693 |
Cleaning compositions containing biostatic agent
The present invention relates to an aqueous cleaning composition containing (a) 1 to 10 weight % of at least one surfactant selected from the group consisting of anionic surfactants and...
|
|
|
5886040 |
Creatine pyruvate salt with enhanced palatability
An organic salt formed between creatine and pyruvic acid and their attendant salts and analogs, is water soluble and possesses improved palatability. The creatine is in a chemical form which...
|
|
|
5883133 |
Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents and medicaments comprising them
Compounds of the formula I ##STR1## are described in which at least one of the substituents R(1), R(2), R(3), R(4) and R(5) is a nitrogen-containing heterocyclic radical. They are outstanding...
|
|
|
5869531 |
Fluoroalkyl substituted benzoylguanidines
Disclosed are 4-(2'-trifluoromethylethyl)benzoylguanidine and 3-methylsulfonyl-4-(2'-trifluoromethylethyl)benzoylguanidine
. Also disclosed are pharmaceutical compositions and the use of the...
|
|
|
5869073 |
Antimicrobial liquid compositions and methods for using them
A liquid composition for applying a non-leachable antimicrobial coating on a surface. The liquid composition consists of a solution, dispersion or suspension of a biguanide polymer reacted with a...
|
|
|
5869534 |
Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
The in vivo oxidation of lipids and lipid-containing molecules has been discovered to be initiated by the concurrent reaction of such lipid materials with reducing sugars such as glucose, advanced...
|
|
|
5856344 |
Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic aid, and medicament containing them
Benzoylguanidines of the formula I ##STR1## in which R(1) to R(6) have the meanings stated in the claims, are antiarrhythmic pharmaceuticals which have excellent activity and a cardioprotective...
|
|
|
5854290 |
Use of guanfacine in the treatment of behavioral disorders
Disclosed is a method of treating disorders which have prominent symptoms of behavioral disinhibition (e.g., Attention-Deficit Hyperactivity Disorder, Conduct Disorder, Oppositional Defiant...
|
|
|
5852009 |
Compositions, including pharmaceutical compositions, for inhibiting the advanced glycosylation of proteins, and therapeutic methods based thereon
The present invention relates to compositions and methods for inhibiting protein aging. Accordingly, a composition is disclosed which comprises an agent or compound capable of inhibiting the...
|
|
|
5849799 |
Use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
Methods are disclosed for treatment of hyperreactive inflammatory diseases of humans and animals comprising administering a pharmaceutically effective amount of deoxyspergualin to a human or an...
|
|
|
5847006 |
Therapeutic guanidines
The present invention provides N,N'-diaryl substituted guanidines having therapeutic utility. The compounds of the present invention are represented by the formula: ##STR1## wherein R and R 1 ...
|
|
|
5837738 |
Method of inhibiting nitric oxide formation
A method is disclosed for inhibiting nitric oxide formation in a warm blooded mammal afflicted with an acute or chronic inflammatory disease which comprises administering to said mammal an...
|
|
|
5830917 |
L-N.sup.6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors
There is disclosed a novel amino alcohol amine derivatives of L-N 6 -(1-iminoethyl)lysine, pharmaceutical compositions containing these novel compounds, and to their use in therapy, in particular...
|
|
|
5801179 |
Vasoconstrictive substituted aryloxyalkyl diamines
The present invention is concerned with compounds having the formula ##STR1## the pharmaceutically acceptable acid addition salts thereof, and the stereochemically isomeric forms thereof, wherein R...
|
|
|
5801200 |
Methods and materials for the diagnosis and treatment of conditions such as stroke
The in vivo oxidation of lipids and lipid-containing molecules has been discovered to be initiated by the concurrent reaction of such lipid materials with reducing sugars such as glucose, advanced...
|
|
|
5795917 |
Enzyme inhibitor acaricides I
The invention provides novel methods of controlling mite infestations of plants. The novel methods employ the step of applying an effective amount of a compound that can inhibit the proteolytic...
|
|
|
5792769 |
Guanidino protease inhibitors
Compounds of the formula: ##STR1## wherein R 1 --R 4 , R 7 --R 8 , R a , R b , R c , Y, Z, n and m are set forth in the specification, as well as hydrates, solvates or pharmaceutically acceptable...
|
|
|
5780513 |
Method of inhibiting the release of bioactive IL-1
A method for the treating an individual afflicted with a disease condition mediated by IL-1 bioactivity is disclosed. The method comprises administering an effective amount of the NOS inhibitor,...
|
|
|
5773469 |
Diaryl antimicrobial agents
The invention relates to diaryl antimicrobial compounds of the general formula: ##STR1## where G, E L, J, q, m, X, Ar, W, p, n and A are as described herein, pharmaceutical compositions containing...
|
|
|
5753710 |
Substituted benzyloxycarbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them
Substituted benzyloxycarbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them. There are described compounds of the formula I...
|
|
|
5753715 |
2-disubstituted cyclohexenyl and cyclohexyl antimicrobial agents
The invention relates to cyclohexenyl antibacterial compounds of the formula I: ##STR1## and pharmaceutical compositions containing the compounds, methods for their production and use.
|
|
|
5741661 |
Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
Modulators of neurotransmitter release including substituted guanidines, N"-aminoguanidines, and N,N'N",N"'-tetrasubstituted hydrazinedicarboximidamides, and pharmaceutical compositions thereof are...
|
|
|
5739142 |
4-aminobenzoylguanidine derivatives
4-Aminobenzoylguanidines of the formula I ##STR1## in which A, R 1 , R 2 and R 3 have the meanings given, and the physiologically unobjectionable salts thereof exhibit antiarrhythmic properties...
|
|
|
5733934 |
Antiarrythmic and cardioprotective substituted indenoylguanidines
Indenoylguanidines of formula I and formula II, the process for their preparation, their use as medicaments, medicaments containing them, their use as diagnostic agents and medicaments containing...
|
|
|
5733932 |
Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
The present invention encompasses the use of the compounds of formula as given below to detect certain specific protein structures which are present in nuclear localization sequences ##STR1##...
|
|
|
5728734 |
Pesticide preparation of aqueous suspension type
A pesticide preparation of aqueous suspension type which comprises: (a) a 1,1'-iminiodi(octamethylene)diguanidinium tris(alkyl-benzenesulfonate) as an active pesticide ingredient; (b) at...
|
|
|
5726146 |
Non-steroidal, anabolic dietary supplement and method to increase lean mass without linked increase fat mass
Dietary supplement formulation which increases lean body mass without concomitant increase of body fat mass, an effect parallel to that seen with usage of synthetic anabolic steroidal compounds but...
|
|
|
5723496 |
Method for prevention and treatment of harmful effects of intracellular acidosis
Compounds and a method useful for protection of tissue cells in a mammalian body from irreversible damages due to lactic acidosis caused by oxygen deficiency. The protection is achieved by...
|
|
|
5719187 |
Compounds having a guanidine structure and pharmaceutical composition containing same
Guanidine derivatives are provided useful for promoting growth, repair and regeneration of a neuronal axon and for treating neuropathies and myopathies. The compounds have the formula: ##STR1##...
|
|
|
5710181 |
Inhibition of nitric oxide formation in inflammatory bowel disease
A method is disclosed for inhibiting nitric oxide formation in a warm blooded mammal afflicted with inflammatory bowel disease which comprises administering to said mammal an effective nitric oxide...
|
|
|
5705531 |
1,5-disubstituted 7A-methylperhydroinden-3A-ol derivatives, useful in treating cardiovascular disorders, processes for their preparation and pharmaceutical compositions containing the same
1,5-Disubstituted 5a-methylperhydroinden-3a-ol derivatives of formula (I): ##STR1## where either the symbol - - - - represents a single bond, the group A is in cis configuration with respect...
|
|
|
5700834 |
Synergistic antimicrobial composition of 1,2-dibromo-2,4-dicyanobutaneand alkylguanidine compounds
Synergistic antimicrobial combinations comprising 1,2-dibromo-2,4-dicyanobutane and an alkylguanidine compound, preferably dodecylguanidine hydrochloride, are disclosed. Methods for inhibiting...
|
|
|
5696138 |
Urea derivatives and their use
A compound having the formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein X, Z, Y, A, D, E, F, R 1 , R 2 , R 3 , R 4 , R 11 , R 12 have the meanings set forth in the...
|
|
|
5693672 |
3,4,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them
3,4,5-Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them Benzoylguanidines of the formula I ##STR1## where R(1) is...
|
|
|
5681861 |
Aminoguanidines and methods of use of same
Modulators of neurotransmitter release including substituted guanidines, N"-aminoguanidines, and N,N'N",N'"-tetrasubstituted hydrazinedicarboximidamides, and pharmaceutical compositions thereof are...
|
|
|
5677349 |
Agmatine for the treatment of neurotrauma and neurodegenerative diseases
The invention relates to the use of agmatine, in the treatment of acute neurotrauma (such as stroke) and degenerative disorders of the central and peripheral nervous system (such as dementia).
|
|
|
5677345 |
Synergistic antimicrobial composition of N- (dichlorofluoromethyl)thio!-N',N'-dimethyl-N-phenylsulfamide and alkylguanidine compounds
Synergistic antimicrobial combinations comprising N- (dichlorofluoromethyl)thio!-N',N'-dimethyl-N-phenylsulfamide
and an alkylguanidine compound, preferably dodecylguanidine hydrochloride, are...
|
|
|
5672608 |
Acenaphthyl substituted guanidines and methods of use thereof
Modulators of neurotransmitter release including substituted guanidines, N"-aminoguanidines, and N,N'N",N'"-tetrasubstituted hydrazinedicarboximidamides, and pharmaceutical compositions thereof are...
|
|
|
5646188 |
Polyamine derivatives of 1-aminoindan
A compound of general formula I ##STR1## wherein n is 1 or 2; R 1 and R 2 are each independently hydrogen, hydroxy, substituted or unsubstituted C 1 -4 alkyl, substituted or unsubstituted C 1 -4...
|
|
|
5646135 |
Method for controlling coccidiosis
The present invention relates to an improved method for controlling coccidiosis in poultry which comprises administering to poultry on shuttle medication an additional medication prior to switching...
|
|
|
5637623 |
Substituted adamantyl guanidines and methods of use there of
Modulators of neurotransmitter release including substituted guanidines, N"-aminoguanidines, and N,N'N",N"'-tetrasubstituted hydrazinedicarboximidamides, and pharmaceutical compositions thereof are...
|